Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer

2019 ◽  
Vol 19 (5) ◽  
pp. 311-316 ◽  
Author(s):  
Maciej M. Mrugala ◽  
Bryan Kim ◽  
Akanksha Sharma ◽  
Natalie Johnson ◽  
Carrie Graham ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Leptomeningeal Carcinomatosis ◽  
High Dose ◽  
Liposomal Cytarabine ◽  
High Dose Methotrexate ◽  
Dose Methotrexate

Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: Results of a phase II study in newly diagnosed children

2002 ◽  
Vol 39 (3) ◽  
pp. 168-174 ◽  
Author(s):  
Stewart J. Kellie ◽  
Christopher K.F. Wong ◽  
Luciano Dalla Pozza ◽  
Keith D. Waters ◽  
Liane Lockwood ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
High Dose ◽  
High Dose Methotrexate ◽  
Newly Diagnosed ◽  
Embryonal Tumors ◽  
Dose Methotrexate

scholarly journals Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer

2001 ◽  
Vol 4 (4) ◽  
pp. 192-197 ◽  
Author(s):  
Shinichiro Takahashi ◽  
Taira Kinoshita ◽  
Masaru Konishi ◽  
Toshio Nakagouri ◽  
Kazuto Inoue ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Phase Ii ◽  
Phase Ii Study ◽  
High Dose ◽  
High Dose Methotrexate ◽  
Scirrhous Gastric Cancer ◽  
Dose Methotrexate
Sign in / Sign up

Export Citation Format

Share Document